Clinical Trials Directory

Trials / Completed

CompletedNCT07187414

Microbiological Description of Sperm and Follicular Fluid Samples. Impact on IVF/ICSI Success Rates

Microbiological Description of Sperm and Follicular Fluid Samples. Impact on IVF/ICSI Success Rates (SPERMIBIOTE)

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
Sex
All
Age
18 Years – 59 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to quantify and identify bacteria that may be present in semen and follicular fluid samples on the day of the IVF-ICSI attempt. The secondary objective is to : * Quantify and identify bacteria that may be present in embryo culture media on day 6. * Correlate microbiological analyses of sperm and follicular fluids with those of embryo culture media on day 6. * Evaluate their impact on fertilization and blastulation rates

Detailed description

This is a single-center observational study based on data contained in the medical records of couples treated and evaluated as part of Medically Assisted Procreation (IVF-ICSI). This study was conducted at the Parly 2 private hospital for data and sample collection, at the Parly 2 hospital microbiology laboratory, and at Life \& Soft Fontenay-aux-Roses for sample analysis. Collected samples will not be stored after analysis. The objective of this study does not impose any particular constraints. The study consists of a single assessment, the data from which will be recorded on an electronic case report form (CRF).

Conditions

Timeline

Start date
2024-01-09
Primary completion
2025-03-29
Completion
2025-03-29
First posted
2025-09-23
Last updated
2025-09-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07187414. Inclusion in this directory is not an endorsement.